Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Hahn

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
FEBS Letters|April 4, 2000
Differential activation of MAP kinase family members triggered by CD99 engagementM J Hahn, S S Yoon, H W Sohn, et al.
Scandinavian Journal of Immunology|May 14, 2004
DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV diseaseR K Gieseler, G Marquitan, M J Hahn, et al.
Molecular Immunology|February 24, 2000
Requirement of MEF2D in the induced differentiation of HL60 promyeloid cellsH H Shin, J Y Seoh, H Y Chung, et al.
British Journal of Haematology|November 11, 1999
Myeloid differentiation of human cord blood CD34+ cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factorE S Yoo, K H Ryu, H Y Park, et al.
Journal of Korean Medical Science|April 6, 2001
Cell cycling status of human cord blood CD34+ cells during ex vivo expansion is related to the level of very late antigen expressionJ Y Seoh, H Y Park, W S Chung, et al.
Scandinavian Journal of Immunology|February 14, 2002
Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietinS-Y Woo, J-H Kie, K-H Ryu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 12, 2017
Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic testsJ-H Ko, M A Müller, H Seok, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
FEBS Letters|April 4, 2000
Differential activation of MAP kinase family members triggered by CD99 engagementM J Hahn, S S Yoon, H W Sohn, et al.
Scandinavian Journal of Immunology|May 14, 2004
DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV diseaseR K Gieseler, G Marquitan, M J Hahn, et al.
Molecular Immunology|February 24, 2000
Requirement of MEF2D in the induced differentiation of HL60 promyeloid cellsH H Shin, J Y Seoh, H Y Chung, et al.
British Journal of Haematology|November 11, 1999
Myeloid differentiation of human cord blood CD34+ cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factorE S Yoo, K H Ryu, H Y Park, et al.
Journal of Korean Medical Science|April 6, 2001
Cell cycling status of human cord blood CD34+ cells during ex vivo expansion is related to the level of very late antigen expressionJ Y Seoh, H Y Park, W S Chung, et al.
Scandinavian Journal of Immunology|February 14, 2002
Megakaryothrombopoiesis during ex vivo expansion of human cord blood CD34+ cells using thrombopoietinS-Y Woo, J-H Kie, K-H Ryu, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 12, 2017
Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic testsJ-H Ko, M A Müller, H Seok, et al.
Pageof 2